Bioequivalence study of two formulations containing 400 mg dexibuprofen in healthy Indian subjects

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 7, 2008, Pages 342-347

  Mandal, Uttam ^a   Das, Ayan ^a   Agarwal, Sangita ^a   Chakraborty, Uday ^a   Nandi, Utpal ^a   Chattaraj, Tapas Kumar ^b   Pal, Tapan Kumar ^a  

^a JADAVPUR UNIVERSITY   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Anti inflammatories, nonsteroidal; CAS 51146 56 6; Dexibuprofen, bioequivalence, pharmacokinetics

Indexed keywords

DEXIBUPROFEN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INDIAN; NORMAL HUMAN; SINGLE DRUG DOSE;

EID: 49449083743     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296517     Document Type: Article

References (30)

1. Busson M. Update on Ibuprofen: review article. J Int Med Res. 1986;14:53-62.
2. Mehlisch DR, Jasper RD, Brown P, Korn SH, McCarroll K, Murakami AA.Comparative study of ibuprofen lysine and acetaminophen in patients with postoperative dental pain. Clin Ther. 1995;17:852-860.
3. Bonenberg E, Zou MH, Ullrich V. Inhibition of cyclooxyge-1 and -2 by R (-) and S(+)-ibuprofen. J Clin Pharmacol. 1996;36:16S-19S.
4. Brideau C, Kargman S, Liu S, Dallob AL, Ehrich EW, Rodger IW, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res. 1996;45:68-72.
5. Young JM, Panah S, Satchawatcharaphong C, Cheung PS. Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and - 2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production. Inflamm Res. 1996:45:246-253.
6. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120.
7. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. No steroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96:7563-7568.
8. Wechter JW, Loughhaed DG, Reischer RJ, VanGiessen GJ, Kaiser DG. Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R (-) p-iso-butyl hydrotropic acid. Biochem Biophys Res Commun. 1974;61: 833-837.
9. Caldwell J, Hutt AJ, Fournel-Gigleux S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol. 1988;37:105-114.
10. Williams KM. Enantiomers in arthritic disorders. Pharmacol Ther. 1990;46:273-295.
11. Greennan DM, Aarons L, Siddiqui M, Richards M, Thompson R, Higham C. Dose- response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings. Br J Clin Pharmacol. 1983;15:311-316.
12. Laska EM, Sunshine A, Marrero I, Olson N, Siegel C, McCormick N. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther. 1986;40:1-7.
13. Bonabello A, Galmozzi MR, Canaparo R, Isaia GC, Serpe L, Muntoni E, et al. Dexibuprofen (S (+)-isomer ibuprofen) reduces gastric damage and improves analgesic and anti-inflammatory effects in rodents. Anesth Analg. 2003;97: 402-408.
14. Dionne RA, McCullagh L. Enhanced analgesia and suppression of plasma β-endorphin by the S (+)-isomerof ibuprofen. Clin Pharmacol Ther. 1998;63:694-701.
15. Mehvar, R, Jamall F, Pasutto FM. Liquid-chromatographic assay of ibuprofen enantiomers in plasma. Clin Chem. 1988;34(3):493-496.
16. Vinci F, Fabbrocino S, Fiori M, Serpe L, Gallo P. Determination of fourteen non- steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2006;20: 3412-3420.
17. Wang P, Qi M, Liu L, Fang L. Determination of ibuprofen in dog plasma by liquid chromatography and application in pharmacokinetic studies of an ibuprofen prodrug in dogs. Journal of Pharmaceutical and Biomedical Analysis. 2005; 38:714-719.
18. Hauschke D, Steinijans V, Diletti E. A distribution free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1990;30:37-43.
19. Schulz HU, Steinijans VW. Striving for standards in bioequivalence assessment: a review. Int J Clin Pharmacol Ther Toxicol. 1992;30:51-56.
20. Farolfi M, Power JD, Rescigno A. On the determination of bioequivalence. Pharmacol. Res. 1999;39:1-4.
21. Mandal U, Musmade P, Chakraborty M, Rajan DS, Chakravarti M, Pal TK, et al. Bioequivalence study of sildenafil citrate tablets in healthy human volunteers. Boll Chim Farmac. 2004;143:345-349.
22. Mandal U, Ganesan M, Pal TK, Jayakumar M, Chattaraj TK, Ray K, et al. Bioequivalence study of rabeprazole sodium on healthy human volunteers. J Indian Med Assoc. 2004;102 (1):26-30.
23. Mandal U, Jayakumar M, Ganesan M, Senthil DR, Pal TK, Gowda, VK. Bioequivalence study on quetiapine fumarate tablets by HPLC. Indian Drugs. 2005;42(6):353-356.
24. Gowda KV, Rajan DS, Mandal U, Selvan PS, Solomon WDS, Bose A, et al. Evaluation of bioequivalence of two formulations containing 100 miligrams of aceclofenac. Drug Development and Industrial Pharmacy. 2006;32:1219-1225.
25. EMEA. Note for guidance on the investigation of bioavailability and bioequivalence. 2002;CPMP/EWP/QWP/1401/98.
26. U. S. Food and Drug Administration. Guidance for Industry: Bioavailability and Bioequivalence studies for orally Administered Drug Products- General Considerations. Rockville, MD: Center for Drug Evaluation and Research. 2000.
27. Committee for Proprietary Medicinal Products (CPMP). Note for Guidance: Investigation of Bioavailability and Bioequivalence. London: Working Party on the Efficacy of the Medicinal Products. 1991.
28. Nation RL, Sansom LN. Bioequivalence requirements for generic products. Pharmacol. Ther. 1994;62:41-55.
29. Shah VP, Midha KK, Sighe S. Analytical method validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Phatrmacokin. 1992;16:249-255.
30. Belen S, Miguel A, Campanero Maria JMJ, Isabel GA, Emilio GQ, et al. A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers. Eur J Clin Pharmacol. 2006;62:849-854.